Literature DB >> 28990808

MicroRNA-205 Mediates Proteinase-Activated Receptor 2 (PAR2) -Promoted Cancer Cell Migration.

Xu Yang1, Lan Yang1, Yiming Ma1, Xinhua Zhao1, Hongying Wang1.   

Abstract

Activation of proteinase-activated receptor 2 (PAR2) promotes cell migration in cancers, but the exact mechanism underlying this process remains largely unknown. Here we report that activation of PAR2 reduced miR-205 expression, whereas inhibition of miR-205 promoted cell migration in cancer cells. Overexpression of miR-205 blocked PAR2-mediated stimulation of cell migration. BMPR1B was identified as a downstream target gene of miR-205. In colorectal carcinoma specimens from patients, the level of PAR2 was negatively correlated with that of miR-205, but it was positively associated with BMPR1B expression. Taken together, our findings indicate that PAR2 signaling promotes cancer cell migration through miR-205/BMPR1B pathway in human colorectal carcinoma.

Entities:  

Keywords:  BMPR1B; Colorectal cancer; Migration; PAR2; miR-205

Mesh:

Substances:

Year:  2017        PMID: 28990808     DOI: 10.1080/07357907.2017.1378671

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  8 in total

1.  Protease activated receptor 2 mediates tryptase-induced cell migration through MYO10 in colorectal cancer.

Authors:  Xiaoli Zhang; Qing Fang; Yiming Ma; Shuangmei Zou; Qian Liu; Hongying Wang
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

2.  The diagnostic value of miR-145 and miR-205 in patients with cervical cancer.

Authors:  Furong Yu; Jie Liu; Weilei Dong; Jing Xie; Xia Zhao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

3.  Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databases.

Authors:  Cheng Chen; Qiang Guo; Yang Tang; Wendong Qu; Jiebin Zuo; Xixian Ke; Yongxiang Song
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 3.005

4.  MicroRNAs as Urinary Biomarker for Oncocytoma.

Authors:  Melanie von Brandenstein; Monika Schlosser; Jan Herden; Axel Heidenreich; Stefan Störkel; Jochen W U Fries
Journal:  Dis Markers       Date:  2018-07-16       Impact factor: 3.464

5.  MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer.

Authors:  Lihua Jiang; Wenchuan Yang; Weishi Bian; Hailin Yang; Xia Wu; Yuhua Li; Wen Feng; Xuejian Liu
Journal:  Oncol Res       Date:  2018-03-01       Impact factor: 5.574

Review 6.  Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.

Authors:  Francesco Trevisani; Matteo Floris; Roberto Minnei; Alessandra Cinque
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

7.  Effect of miR-205 on proliferation and migration of thyroid cancer cells by targeting CCNB2 and the mechanism.

Authors:  Xin Wang; Haomin Zhang; Kai Jiao; Chunyang Zhao; Hailong Liu; Qinghong Meng; Zhao Wang; Chunling Feng; Yuanchun Li
Journal:  Oncol Lett       Date:  2020-01-24       Impact factor: 2.967

Review 8.  miR-205: A Potential Biomedicine for Cancer Therapy.

Authors:  Neeraj Chauhan; Anupam Dhasmana; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Cells       Date:  2020-08-25       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.